Showing results (2671-2680 of 3,872) with videos related to

Sort By:
Pageof 388
Cancer Biology & Therapy|February 11, 2020
The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesisAbeer Al-Abdallah, Iman Jahanbani, Heba Mehdawi, et al.
Cancer Biology & Therapy|February 11, 2020
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axisErik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, et al.
Cancer Biology & Therapy|November 8, 2019
STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivoQing Yang, Guoxin Ji, Jiyu Li
Cancer Biology & Therapy|August 17, 2017
Metastatic colon adenocarcinoma has a significantly elevated expression of IL-10 compared with primary colon adenocarcinoma tumorsMichelle H Townsend, Abigail M Felsted, Stephen R Piccolo, et al.
Cancer Biology & Therapy|March 28, 2018
A rare case of multicentric castleman's disease transforms into multiple myeloma and its successful treatmentDan Yang, Xuan Zhou, Youcai Zhao, et al.
Cancer Biology & Therapy|March 28, 2018
Natural dietary compound naringin prevents azoxymethane/dextran sodium sulfate-induced chronic colorectal inflammation and carcinogenesis in miceYu-Sheng Zhang, Feng Wang, Shu-Xiang Cui, et al.
Cancer Biology & Therapy|March 28, 2018
Comparison of EpCAMhighCD44+ cancer stem cells with EpCAMhighCD44- tumor cells in colon cancer by single-cell sequencingMingshan Liu, Jiabo Di, Yang Liu, et al.
Cancer Biology & Therapy|March 28, 2018
Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behaviorIlaria Giusti, Marianna Di Francesco, Sandra D'Ascenzo, et al.
Cancer Biology & Therapy|March 28, 2018
Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapiesAnthony R Mato, Jennifer C Samp, Geneviève Gauthier, et al.
Cancer Biology & Therapy|November 6, 2019
Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patientsYang Peng, Rui Chen, Fanli Qu, et al.
Pageof 388